Evaluation of Probiotics on Symptoms of Upper Respiratory Tract Infections
NCT ID: NCT00599430
Last Updated: 2008-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
326 participants
INTERVENTIONAL
2005-11-30
2006-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Efficacy of a Probiotic Product on Acute Upper Respiratory Tract Infections (Common Cold) in Healthy Children
NCT02640352
A Study to Assess the Effect of a Probiotic on Upper Respiratory Tract Infections in Healthy Children
NCT05577065
Probiotics in Respiratory Tract Infections in Children
NCT01510938
The Effect of a Probiotic on Upper Respiratory Tract Infections
NCT03636191
Efficacy and Safety of L. Plantarum and P. Acidilactici in Children With Upper Respiratory Tract Infections
NCT05279534
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Placebo
Placebo
Inert excipient
Active 1
One probiotic strain
Lactobacillus acidophilus NCFM
1e10 CFU/day
Active 2
Blend of two strains
Combination of Lactobacillus acidophilus and Bifidobacterium lactis
1x10e10 CFU/day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo
Inert excipient
Lactobacillus acidophilus NCFM
1e10 CFU/day
Combination of Lactobacillus acidophilus and Bifidobacterium lactis
1x10e10 CFU/day
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Indicators of inflammatory disease, intestinal disease, Crohn's disease, colitis, celiac disease
* Chronic cough from recurring respiratory distress-related diseases
* Hirschsprung's disease
* Cystic fibrosis
* Other metabolic, neurological, or anatomic alteration that predisposes participation
* Intake of probiotics within the last 3 weeks
3 Years
5 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Danisco
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Danisco
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Charlie Zhang
Role: STUDY_DIRECTOR
Sprim Advanced Life Sciences
Cheryl Riefer
Role: STUDY_CHAIR
Sprim Advanced Life Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Day care center
Jinhua, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Leyer GJ, Li S, Mubasher ME, Reifer C, Ouwehand AC. Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics. 2009 Aug;124(2):e172-9. doi: 10.1542/peds.2008-2666. Epub 2009 Jul 27.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
06-02-D-011
Identifier Type: -
Identifier Source: secondary_id
Danisco - Mao
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.